Nasdaq

Biosynex Secures Grant for Syphilis Diagnostic Test

Biosynex SA (FR:ALBIO) has released an update. Biosynex’s subsidiary, Chembio Diagnostics, has received a $1.5 million grant from the Bill & Melinda Gates Foundation to develop a rapid diagnostic test ...
Nasdaq

Biosynex SA Expands Global Reach in Diagnostics

Biosynex SA (FR:ALBIO) has released an update. Biosynex SA, a leader in health diagnostics, reported a turnover of €93 million in 2023 and has expanded its international presence with subsidiaries in ...
Seeking Alpha

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

STRASBOURG, France and HAUPPAUGE, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, and ...
Reuters

Biosynex obtains CE mark for Exacto Pro Test HIV

Feb 16 (Reuters) - Biosynex SA : * Obtains CE mark for rapid serological test new generation of infection by HIV 1 and 2 responsible for AIDS (Exacto Pro Test HIV) Source text: bit.ly/215UZVd Further ...
Business Wire

BIOSYNEX Announces the Great Success of Its Capital Increase Through Placement With Qualified Investors for an Amount of €15m

BIOSYNEX shares, or any other security, may only be offered or sold in the United States of America following registration under the US Securities Act of 1933, as amended (the "Securities Act ”), or ...